Skip to main content
. 2010 Apr 28;285(29):22017–22026. doi: 10.1074/jbc.M110.108548

TABLE 1.

GPI anchor analogues reduced the PrPSc content of ScN2a and SMB cells

ScN2a or SMB cells were treated daily with GPI anchor analogues as shown for 7 days, and the amount of cell-associated PrPSc was determined using a PrP ELISA. Values given are the mean average amount of PrPSc (pg/106 cells) ± S.D., n = 12.

Treatment PrPSc (pg/106 cells)
ScN2a SMB
None 2128 ± 95 6057 ± 639
Vehicle control 2096 ± 140 5988 ± 458
1 μm glucosamine-PI <50a <50a
1 μm glucosamine-O-methyl inositol octadecyl phosphate 186 ± 120a 748 ± 161a
50 μm glucosamine 2318 ± 92 5789 ± 634
50 μm galactosamine 1988 ± 221 6255 ± 589
50 μm galactose 2090 ± 320 6425 ± 663
50 μm mannose 2150 ± 337 6271 ± 713

a Amount of PrPSc is significantly less than that of vehicle-treated cells (p < 0.01).